Relypsa Obtains $12,734,652 New Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=753be57d-dde0-4877-be6e-89a9462014ed&Preview=1 -
Date
10/8/2012 -
Company Name
Relypsa -
Mailing Address
5301 Patrick Henry Drive Santa Clara, CA 95054 -
Company Description
Relypsa, Inc. is a biopharmaceutical company leading the discovery and development of new non-absorbed polymeric drugs for important applications in renal and cardiovascular disease. -
Website
http://www.relypsa.com -
Transaction Type
Venture Equity -
Transaction Amount
$12,734,652 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing-amended. -
M&A Terms
-
Venture Investor
Undisclosed
